Invitation to Publish in Rheumatology Network

We invite our physician readers to contribute commentaries, reviews, case studies and image IQs on rheumatic disease and related issues.

Rheumatology Network provides a platform for physicians to communicate with colleagues by sharing successes, best practices, perplexing case studies and more. We invite our physician readers to contribute commentaries, reviews, case studies and image IQs on rheumatic disease and related issues. Fibromyalgia, giant cell arteritis, glucocorticoid use, gout, juvenile arthritis, lupus, osteoarthritis, osteoporosis, psoriatic arthritis, rheumatoid arthritis, Sjögren's syndrome, spondyloarthritis, vasculitis - include some of the subjects we cover. Email the editor. Publishing in Rheumatology Network offers a number of benefits: Reach: Rheumatology Network is part of UBM Medica, a network of online publications for physicians. In addition to our thousands of subscribers, Rheumatology Network has thousands of more followers in social media. Resources:  We follow new developments in clinical research. Each article includes links to related studies. Bridging the gap in communications: Our goal is to foster physician discussions about best practices and issues affecting the private practice, academic and health system physicians. Seeking new contributors for sections on: Lupus, rheumatoid arthritis, bone issues, drug safety, education, pain, imaging and healthcare policy issues. Each submission comes with a small honorarium. A selection of content from Rheumatology Network 

 

 

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
A panel of 5 experts on iron deficiency anemia
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
© 2024 MJH Life Sciences

All rights reserved.